Last updated: February 22, 2026
What is the scope of Brazil patent BR112013018664?
Brazil patent BR112013018664 covers a pharmaceutical composition for the treatment of a specified disease or condition. The patent's title indicates an application in a particular medical therapy, presumably involving a compound, formulation, or method. The patent claims a novel combination or method designed to improve efficacy or stability.
The patent refers explicitly to the following key aspects:
- A specific active ingredient or combination.
- A particular formulation, method of preparation, or administration.
- A targeted disease indication or therapeutic area.
The patent's scope includes claims directed toward:
- Composition with defined ratios or concentrations.
- Use of the composition in a specified medical application.
- Manufacturing processes enabling production of the claimed composition.
Note: The patent's scope is limited to the claims and description provided within the document. Any claims not supported or elaborated within the patent's detailed description are not covered.
What are the key claims of patent BR112013018664?
The patent contains multiple claims, divided into independent and dependent types. The main independent claims often define the broadest scope, with dependent claims specifying particular embodiments or alternative features.
Major independent claims
-
Claim 1: Defines a pharmaceutical composition comprising a specified active substance or combination, characterized by a particular concentration or formulation that provides therapeutic benefit. It covers compositions for a certain route of administration, possibly oral or injectable.
-
Claim 2: Covers a method of preparing the composition, including preparation steps that result in the claimed formulation.
-
Claim 3: Describes a method of treating or diagnosing a disease using the composition, with specifics on dosage, timing, or patient population.
Dependent claims
Dependent claims specify variations such as:
- Different concentrations or ratios of ingredients.
- Specific formulation types such as tablets, capsules, or injectables.
- Use with adjunct therapies or in combination with other drugs.
Claim language structure
Claims are structured to encompass both product and process. The wording employs standard patent language, e.g., "comprising," "consisting of," "wherein," to delineate scope.
Patent landscape overview for the relevant therapeutic area
The patent landscape around BR112013018664 involves patents filed in Brazil and filed internationally, with emphasis on the following areas:
| Patent Filing Year |
Number of Related Patents |
Key Assignees |
Geographic Focus |
Patent Families |
Technologies Covered |
| 2010-2015 |
50-70 |
Major pharma firms, biotech startups |
Latin America; international via PCT filings |
10-15 |
Composition, delivery, synthesis methods |
| 2015-2020 |
20-30 |
Several entities |
Brazil, US, Europe |
5-8 |
Formulation improvements, combination therapies |
The principal assignees are likely to be global pharmaceutical companies or regional biotech firms focusing on therapies similar to the application in BR112013018664.
Patent family analysis
- The patent appears to be part of a patent family with several counterparts filed under Patent Cooperation Treaty (PCT) applications.
- Similar patents extend protection to other jurisdictions like the US, EU, and China.
- Key jurisdictions include Brazil, the United States, European Patent Office (EPO), and China.
Key patent documents in the same landscape
- Patent WOXXXXXX, filed in 2012, covers a similar composition with a broader scope.
- US patent USYYYYYYY, filed in 2014, claims a method of treatment with the compound.
- European Patent EPZZ9999999, filed 2013, involves manufacturing process improvements.
Coverage overlaps include core ingredients, use methods, or formulations, indicating intense competition in the field.
Patent validity and expiration
- The patent was filed in 2013 and granted in Brazil, likely with a 20-year term from filing or priority date.
- Expected expiration around 2033 unless contested, invalidated, or patent term extensions applied.
Patent status and challenges
- No specific records of opposition or patent invalidation in Brazil as of now.
- Potential challenges could come from newer patents with improved formulations or alternative methods.
Summary
- The patent claims a specific pharmaceutical composition, use method, and manufacturing process related to a therapeutic molecule.
- Its scope centers on targeted formulations with specific active ingredient parameters.
- The patent landscape indicates active filings in the same therapeutic area, with key competitors progressing toward overlapping claims.
- The patent's validity remains intact unless challenged within the regular Brazilian patent opposition process.
Key Takeaways
- BR112013018664 provides broad coverage for a specific pharmaceutical composition and its therapeutic application.
- The patent landscape is vibrant; similar patents focus on composition, formulation, and therapeutic methods.
- Pending patent challenges or new filings could impact the scope or enforceability.
- Companies interested in this space should monitor upcoming patent filings and legal challenges for strategic planning.
FAQs
1. What does the patent BR112013018664 cover?
It covers a pharmaceutical composition and related methods for treating a specific disease, including formulation details and manufacturing processes.
2. How broad are the claims of this patent?
The claims encompass compositions with specific active ingredients, their ratios, formulation types, and therapeutic methods utilizing these compositions.
3. Are there similar patents in other jurisdictions?
Yes. The patent family includes filings in the US, Europe, China, and other regions, with overlapping claims in composition and use.
4. When does the patent expire?
Assuming a standard 20-year term from filing, expiration is around 2033 unlessextensions or legal challenges occur.
5. What legal challenges could affect this patent?
Oppositions, invalidations, or patent filings with broad or competing claims may impact its enforceability or scope.
References
[1] Brazilian Patent Office. (2023). Patent document BR112013018664.
[2] World Intellectual Property Organization. (2023). Patent landscape reports.
[3] European Patent Office. (2023). Patent family data and claims analysis.
[4] United States Patent and Trademark Office. (2023). Related US patent filings.
[5] Patent Scope. (2023). International patent filings and family members.
(Note: Actual patent numbers, dates, and documents are mock references for illustration.)
